ASX 200 (ASX:XJO) midday update: Incitec Pivot and Mesoblast jump, NAB drops

Man looks shocked as he works on laptop on top a skyscraper with stockmarket figures in graphic behind him.

At lunch on Monday, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a solid gain. The benchmark index is currently up 0.4% to 7,472.9 points.

Here’s what is happening on the ASX 200 today:

Incitec Pivot results impress

The Incitec Pivot Ltd (ASX: IPL) share price jumped as much as 17% this morning following the release of its full year results. As management promised, Incitec Pivot delivered a strong second half performance. This led to the agricultural chemicals company reporting a 10% lift in full year revenue to $4,348.5 million and 91% jump in net profit after tax (NPAT) excluding individually material items to $209 million. This was driven by a strong performance from its Fertilisers APAC business, which benefited from a commodity price upswing and strong ammonium phosphates production.

Mesoblast shares jump

The Mesoblast limited (ASX: MSB) share price is charging higher today after the allogeneic cellular medicines developer released positive data from a phase three trial of rexlemestrocel-L in 565 patients with New York Heart Association (NYHA) class II and class III chronic heart failure (CHF) with reduced ejection fraction (HFrEF). Among other things, the study notes that a single dose of rexlemestrocel-L on top of standard of care reduced the incidence of heart attacks or strokes by 65% across all 537 NYHA class II or class III treated patients compared with standard of care alone.

NAB shares fall

The National Australia Bank Ltd (ASX: ANZ) share price is trading lower on Monday. However, this has nothing to do with its performance. Today’s decline is attributable to the banking giant’s shares trading ex-dividend for its final dividend for FY 2021. Last week NAB declared a fully franked final dividend of 67 cents per share with its full year results. Eligible NAB shareholders can look forward to receiving this latest dividend on 15 December.

Best and worst ASX 200 performers

The best performer on the ASX 200 on Monday has been the Mesoblast share price with a 10% gain. This follows its trial update this morning. The worst performer on the ASX 200 has been the Ampol Ltd (ASX: ALD) share price with a decline of almost 3%. This is despite there being no news out of the fuel retailer.

The post ASX 200 (ASX:XJO) midday update: Incitec Pivot and Mesoblast jump, NAB drops appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3Dky4hY

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s